Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.3300 (-5.28%) ($2.3300 - $2.3300) on Tue. Apr. 26, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4% (three month average) | RSI | 20 | Latest Price | $2.3300(-5.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2% a day on average for past five trading days. | Weekly Trend | CGEN declines -10.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) IVW(98%) IWF(98%) VUG(98%) XLI(98%) EWI(97%) | Factors Impacting CGEN price | CGEN will decline at least -2% in a week (0% probabilities). TIP(-12%) SHY(-8%) UUP(-3%) USO(7%) BNDX(11%) | | | | | Relative Volatility | | | | Market Trend Strength | -2% (StdDev 4%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-20.27(-969.96%) | Resistance Level | $2.84 | 5 Day Moving Average | $2.43(-4.12%) | 10 Day Moving Average | $2.53(-7.91%) | 20 Day Moving Average | $2.84(-17.96%) | To recent high | -35.2% | To recent low | 0% | Market Cap | $193m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |